Literature DB >> 21867816

Defining severe pneumonia.

Samuel M Brown1, Nathan C Dean.   

Abstract

Pneumonia is an important clinical and public health problem. Identification and prediction of severe pneumonia are significant concerns. Attempts to define severe pneumonia should recognize that different purposes are served by different definitions; no single definition meets all needs. At present, several prediction models have been proposed or validated. Biomarkers are not yet ready for routine use. The authors recommend careful consideration of the implications of any given definition of pneumonia severity. Outcome studies are needed to integrate human and health care system factors with the application of pneumonia severity definitions.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21867816      PMCID: PMC3163061          DOI: 10.1016/j.ccm.2011.05.001

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  116 in total

1.  The impact of a delay in intensive care unit admission for community-acquired pneumonia.

Authors:  J Phua; W J Ngerng; T K Lim
Journal:  Eur Respir J       Date:  2010-02-25       Impact factor: 16.671

2.  Failure of intensive care unit support to influence mortality from pneumococcal bacteremia.

Authors:  E W Hook; C A Horton; D R Schaberg
Journal:  JAMA       Date:  1983-02-25       Impact factor: 56.272

3.  Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury.

Authors:  Roger G Spragg; Friedemann J H Taut; James F Lewis; Peter Schenk; Clemens Ruppert; Nathan Dean; Kenneth Krell; Andreas Karabinis; Andreas Günther
Journal:  Am J Respir Crit Care Med       Date:  2010-12-10       Impact factor: 21.405

4.  A hospital study of community acquired pneumonia in the elderly.

Authors:  P Venkatesan; J Gladman; J T Macfarlane; D Barer; P Berman; W Kinnear; R G Finch
Journal:  Thorax       Date:  1990-04       Impact factor: 9.139

5.  Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia.

Authors:  Mehdi Mirsaeidi; Paula Peyrani; Stefano Aliberti; Giovanni Filardo; Jose Bordon; Francesco Blasi; Julio A Ramirez
Journal:  Chest       Date:  2009-10-16       Impact factor: 9.410

6.  The modified APACHE II score outperforms Curb65 pneumonia severity score as a predictor of 30-day mortality in patients with methicillin-resistant Staphylococcus aureus pneumonia.

Authors:  Katherine E Kollef; Richard M Reichley; Scott T Micek; Marin H Kollef
Journal:  Chest       Date:  2007-10-20       Impact factor: 9.410

Review 7.  Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia.

Authors:  Veronica Brito; Michael S Niederman
Journal:  Curr Opin Infect Dis       Date:  2009-06       Impact factor: 4.915

8.  Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae.

Authors:  Paschalina Kontou; Joseph L Kuti; David P Nicolau
Journal:  Am J Emerg Med       Date:  2009-10       Impact factor: 2.469

9.  Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database.

Authors:  Mark Woodhead; Catherine A Welch; David A Harrison; Geoff Bellingan; Jon G Ayres
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

10.  Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.

Authors:  Beat Müller; Stephan Harbarth; Daiana Stolz; Roland Bingisser; Christian Mueller; Jörg Leuppi; Charly Nusbaumer; Michael Tamm; Mirjam Christ-Crain
Journal:  BMC Infect Dis       Date:  2007-03-02       Impact factor: 3.090

View more
  3 in total

1.  Health promotion, risk stratification, and treatment options to decrease hospitalization rates for community-acquired pneumonia in adults.

Authors:  Cherese Severson; Collette Renstrom; Meg Fitzhugh
Journal:  J Am Assoc Nurse Pract       Date:  2013-09-03       Impact factor: 1.165

2.  Stroke among highly active antiretroviral therapy-naive people living with the human immunodeficiency virus in China: a retrospective study of the characteristics, risk factors, and prognosis.

Authors:  Ling Zhang; Yu Wang; Qiuhua Xu; Wei Zhang; Hongyuan Liang; Liang Wu; Liang Ni; Guiju Gao; Di Yang; Hongxin Zhao; Jiang Xiao
Journal:  BMC Infect Dis       Date:  2022-01-04       Impact factor: 3.090

3.  Disease-specific dynamic biomarkers selected by integrating inflammatory mediators with clinical informatics in ARDS patients with severe pneumonia.

Authors:  Chengshui Chen; Lin Shi; Yuping Li; Xiangdong Wang; Shuanying Yang
Journal:  Cell Biol Toxicol       Date:  2016-04-19       Impact factor: 6.691

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.